|
|
||||||||
Departments of Anatomy and Physiology and Diagnostic Medicine/Pathobiology, Kansas State University, Manhattan, Kansas
Submitted 7 February 2005 ; accepted in final form 16 May 2005
We tested the hypothesis that central angiotensin II (ANG II) administration would activate splenic sympathetic nerve discharge (SND), which in turn would alter splenic cytokine gene expression. Experiments were completed in sinoaortic nerve-lesioned, urethane-chloralose-anesthetized, splenic nerve-intact (splenic-intact) and splenic nerve-lesioned (splenic-denervated) Sprague-Dawley rats. Splenic cytokine gene expression was determined using gene-array and real-time RT-PCR analyses. Splenic SND was significantly increased after intracerebroventricular administration of ANG II (150 ng/kg, 10 µl), but not artificial cerebrospinal fluid (aCSF). Splenic mRNA expression of IL-1
, IL-6, IL-2, and IL-16 genes was increased in ANG II-treated splenic-intact rats compared with aCSF-treated splenic-intact rats. Splenic IL-1
, IL-2, and IL-6 gene expression responses to ANG II were significantly reduced in splenic-denervated compared with splenic-intact rats. Splenic gene expression responses did not differ significantly in ANG II-treated splenic-denervated and aCSF-treated splenic-intact rats. Splenic blood flow responses to intracerebroventricular ANG II administration did not differ between splenic-intact and splenic-denervated rats. These results provide experimental support for the hypothesis that ANG II modulates the immune system through activation of splenic SND, suggesting a novel relation between ANG II, efferent sympathetic nerve outflow, and splenic cytokine gene expression.
splenic sympathetic nerve discharge; splenic cytokine gene expression
This article has been cited by other articles:
![]() |
H. E. Lob, P. J. Marvar, T. J. Guzik, S. Sharma, L. A. McCann, C. Weyand, F. J. Gordon, and D. G. Harrison Induction of Hypertension and Peripheral Inflammation by Reduction of Extracellular Superoxide Dismutase in the Central Nervous System Hypertension, February 1, 2010; 55(2): 277 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rosas-Ballina, M. Ochani, W. R. Parrish, K. Ochani, Y. T. Harris, J. M. Huston, S. Chavan, and K. J. Tracey Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia PNAS, August 5, 2008; 105(31): 11008 - 11013. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Ganta, B. G. Helwig, F. Blecha, R. R. Ganta, R. Cober, S. Parimi, T. I. Musch, R. J. Fels, and M. J. Kenney Hypothermia-enhanced splenic cytokine gene expression is independent of the sympathetic nervous system Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R558 - R565. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |